SecBot SecBot
8-K ·Filed Nov 5, 2026

FOCL

EDAP TMS SA
NEUTRAL
Impact 5/10
Horizonweeks Processed11d 7h ago SEC0001171843-26-007181
8-K Item 2.02: Earnings release
Actionable Insight • Neutral

Revenue missed consensus by 15%, but EPS beat on non-cash warrant gains. The narrowed guidance midpoint ($51M) is unchanged from the prior midpoint, suggesting no fundamental change in full-year expectations. Monitor Q4 system sales and procedure volume trends to assess whether the revenue trajectory supports the guidance range.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$3.32
T+0 close · Nov 5, 2026 · via day close
Latest settled
−2.26%
T+5 · $3.25
Vs SPY
−4.85%
α at T+5
Next horizon
T+20
in 20d
  1. T+0 · Nov 6 $3.32entry
  2. T+1 · 8d ago +6.02%α +3.66% · $3.52
  3. T+5 · 4d ago −2.26%α −4.85% · $3.25
  4. T+6 · todayOpen
  5. T+20 · in 20d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

FocalTherics (FOCL) reported Q3 2026 revenue of $9.8M (+26% YoY) and a net loss of $4.5M ($0.10 per share), narrowing from a $5.9M loss in Q3 2025. The company narrowed its full-year 2026 revenue guidance to $50M-$52M from $50M-$54M, representing 34%-39% growth. Revenue missed the $11.5M consensus estimate, while EPS of -$0.10 beat the -$0.26 consensus due to a favorable $2.6M non-cash warrant revaluation gain.

Key Financial Metrics

EPS
−$0.10
est −$0.26 · +61.5%
Revenue
$9.8M
est $11.5M · -14.5% · +25.6% YoY
Rating
in line
Guidance
$50.0M-$52.0M
maintained
Free Cash Flow
-$14.0M
Gross Margin
51.4%

Key Facts

  • Q3 2026 revenue $9.8M, up 26% YoY from $7.8M
  • Net loss $4.5M ($0.10 per share) vs $5.9M loss ($0.16 per share) in Q3 2025
  • Gross margin improved to 51.4% from 46.6% YoY
  • Seven Focal One systems sold vs six in prior year period
  • U.S. procedure volume grew 32% YoY
  • Full-year 2026 revenue guidance narrowed to $50M-$52M from $50M-$54M
  • Cash and equivalents $56.3M at Sept 30, 2026, up from $21.5M at June 30, 2026
  • Operating loss widened to $7.8M from $6.7M YoY
  • Net loss improvement driven by $2.6M non-cash gain on warrant revaluation

Financial Impact

Revenue $9.8M vs consensus $11.5M (miss of $1.7M); EPS -$0.10 vs consensus -$0.26 (beat of $0.16); guidance narrowed to $50M-$52M from $50M-$54M

revenueepsgross marginguidance

Segment Breakdown

SegmentRevenueGrowth
HIFU Division$9.8M+25.6%

Risk Factors

  • Revenue of $9.8M missed the $11.5M consensus estimate by 15%
  • Operating loss widened to $7.8M from $6.7M YoY as SG&A grew 29%
  • EPS beat was driven by non-cash warrant revaluation gains, not operational improvement
  • Guidance narrowed but midpoint unchanged, implying Q4 revenue must be $30.4M-$32.4M to hit the full-year range, a significant sequential ramp

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
73% bullish (11 analysts)

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001171843-26-007181
Document: f8k_110526.htm0001171843-26-007181
Document: 0001171843-26-007181-index-headers.html0001171843-26-007181
Document: 0001171843-26-007181-index.html0001171843-26-007181
Document: 0001171843-26-007181.txt0001171843-26-007181
8-K Data (Synthetic)0001171843-26-007181

Track record

9 reports on FOCL

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +26.05% at T+60 after the Aug 14, 2026 report. 2 of 3 went positive at some point.

Filters
  1. Nov 5, 202611d ago 8-K Neutral 5/10 Viewing Entry $3.32 Now $3.17 −4.52% settles Feb 4
  2. Oct 22, 202625d ago Press Release Neutral 1/10 Entry $4.15 Now $3.17 −23.61% settles Jan 21
  3. Oct 19, 202628d ago SC 13G Neutral 3/10 Entry $4.07 Now $3.17 −22.11% settles Jan 14
  4. Aug 19, 202612w ago 8-K Bearish 6/10 Entry $4.36 to $3.41 Now $3.17 +27.29% ▲ +21.79% +20.24% vs SPY
  5. Aug 14, 202613w ago 8-K Bearish 6/10 Entry $4.76 to $3.52 Now $3.17 +33.40% ▲ +26.05% +23.00% vs SPY
  6. Aug 13, 202613w ago 8-K Mixed 6/10 Entry $4.76 to $3.52 Now $3.17 −33.40% ▼ −26.05% −23.00% vs SPY
  7. Aug 11, 202613w ago Press Release Mixed 6/10 Entry $4.75 to $4.25 Now $3.17 −33.26% ▼ −10.53% −5.41% vs SPY
  8. Aug 11, 202613w ago 8-K Bullish 7/10 Entry $4.75 to $4.25 Now $3.17 −33.26% ▼ −10.53% −5.41% vs SPY
  9. Jul 30, 202615w ago Press Release Neutral 1/10 Entry $6.12 to $4.23 Now $3.17 −48.20% ▼ −30.88% −33.34% vs SPY
Showing 9 of 9

US Market Status

Market Closed · Opens Wed (9h 49m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026